200 related articles for article (PubMed ID: 34375644)
21. Sulfatide with short fatty acid dominates in astrocytes and neurons.
Isaac G; Pernber Z; Gieselmann V; Hansson E; Bergquist J; Månsson JE
FEBS J; 2006 Apr; 273(8):1782-90. PubMed ID: 16623713
[TBL] [Abstract][Full Text] [Related]
22. Gene therapy in metachromatic leukodystrophy.
Sevin C; Cartier-Lacave N; Aubourg P
Int J Clin Pharmacol Ther; 2009; 47 Suppl 1():S128-31. PubMed ID: 20040324
[TBL] [Abstract][Full Text] [Related]
23. Bone marrow stem cell-based gene transfer in a mouse model for metachromatic leukodystrophy: effects on visceral and nervous system disease manifestations.
Matzner U; Hartmann D; Lüllmann-Rauch R; Coenen R; Rothert F; Månsson JE; Fredman P; D'Hooge R; De Deyn PP; Gieselmann V
Gene Ther; 2002 Jan; 9(1):53-63. PubMed ID: 11850723
[TBL] [Abstract][Full Text] [Related]
24. Engineered arylsulfatase A with increased activity, stability and brain delivery for therapy of metachromatic leukodystrophy.
Yaghootfam C; Sylvester M; Turk B; Gieselmann V; Matzner U
Mol Ther; 2023 Oct; 31(10):2962-2974. PubMed ID: 37644722
[TBL] [Abstract][Full Text] [Related]
25. Biochemical pathogenesis of genetic leukodystrophies: comparison of metachromatic leukodystrophy and globoid cell leukodystrophy (Krabbe's disease).
Suzuki K
Neuropediatrics; 1984 Sep; 15 Suppl():32-6. PubMed ID: 6152811
[TBL] [Abstract][Full Text] [Related]
26. Coexpression of formylglycine-generating enzyme is essential for synthesis and secretion of functional arylsulfatase A in a mouse model of metachromatic leukodystrophy.
Takakusaki Y; Hisayasu S; Hirai Y; Shimada T
Hum Gene Ther; 2005 Aug; 16(8):929-36. PubMed ID: 16076251
[TBL] [Abstract][Full Text] [Related]
27. Generation of Human Induced Pluripotent Stem Cell-Derived Bona Fide Neural Stem Cells for Ex Vivo Gene Therapy of Metachromatic Leukodystrophy.
Meneghini V; Frati G; Sala D; De Cicco S; Luciani M; Cavazzin C; Paulis M; Mentzen W; Morena F; Giannelli S; Sanvito F; Villa A; Bulfone A; Broccoli V; Martino S; Gritti A
Stem Cells Transl Med; 2017 Feb; 6(2):352-368. PubMed ID: 28191778
[TBL] [Abstract][Full Text] [Related]
28. Embryonic stem cell-based reduction of central nervous system sulfatide storage in an animal model of metachromatic leukodystrophy.
Klein D; Schmandt T; Muth-Köhne E; Perez-Bouza A; Segschneider M; Gieselmann V; Brüstle O
Gene Ther; 2006 Dec; 13(24):1686-95. PubMed ID: 16871228
[TBL] [Abstract][Full Text] [Related]
29. Metachromatic leukodystrophy and pseudoarylsulfatase A deficiency in a Danish family.
Tønnesen T; Bro PV; Brøndum Nielsen K; Lykkelund C
Acta Paediatr Scand; 1983 Mar; 72(2):175-8. PubMed ID: 6132516
[TBL] [Abstract][Full Text] [Related]
30. Brain MRI and biological diagnosis in five Tunisians MLD patients.
Barboura I; Hadded S; Chebel S; Ben Mansour R; Chahed H; Gueddiche MN; Frih-Ayed M; Ferchichi S; Miled A
Diagn Pathol; 2012 Jan; 7():11. PubMed ID: 22284439
[TBL] [Abstract][Full Text] [Related]
31. Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice.
Biffi A; Capotondo A; Fasano S; del Carro U; Marchesini S; Azuma H; Malaguti MC; Amadio S; Brambilla R; Grompe M; Bordignon C; Quattrini A; Naldini L
J Clin Invest; 2006 Nov; 116(11):3070-82. PubMed ID: 17080200
[TBL] [Abstract][Full Text] [Related]
32. Late juvenile metachromatic leukodystrophy (MLD) in three patients with a similar clinical course and identical mutation on one allele.
Tylki-Szymanska A; Berger J; Löschl B; Lugowska A; Molzer B
Clin Genet; 1996 Nov; 50(5):287-92. PubMed ID: 9007312
[TBL] [Abstract][Full Text] [Related]
33. Enzyme replacement improves nervous system pathology and function in a mouse model for metachromatic leukodystrophy.
Matzner U; Herbst E; Hedayati KK; Lüllmann-Rauch R; Wessig C; Schröder S; Eistrup C; Möller C; Fogh J; Gieselmann V
Hum Mol Genet; 2005 May; 14(9):1139-52. PubMed ID: 15772092
[TBL] [Abstract][Full Text] [Related]
34. Metachromatic leukodystrophy: recent research developments.
Gieselmann V
J Child Neurol; 2003 Sep; 18(9):591-4. PubMed ID: 14572136
[TBL] [Abstract][Full Text] [Related]
35. Genotype-phenotype relationship in various degrees of arylsulfatase A deficiency.
Kappler J; Leinekugel P; Conzelmann E; Kleijer WJ; Kohlschütter A; Tønnesen T; Rochel M; Freycon F; Propping P
Hum Genet; 1991 Mar; 86(5):463-70. PubMed ID: 1673113
[TBL] [Abstract][Full Text] [Related]
36. Safety of intrathecal delivery of recombinant human arylsulfatase A in children with metachromatic leukodystrophy: Results from a phase 1/2 clinical trial.
Í Dali C; Sevin C; Krägeloh-Mann I; Giugliani R; Sakai N; Wu J; Wasilewski M
Mol Genet Metab; 2020; 131(1-2):235-244. PubMed ID: 32792226
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of enzyme replacement therapy in an aggravated mouse model of metachromatic leukodystrophy declines with age.
Matthes F; Stroobants S; Gerlach D; Wohlenberg C; Wessig C; Fogh J; Gieselmann V; Eckhardt M; D'Hooge R; Matzner U
Hum Mol Genet; 2012 Jun; 21(11):2599-609. PubMed ID: 22388935
[TBL] [Abstract][Full Text] [Related]
38. Compound heterozygosity for metachromatic leukodystrophy and arylsulfatase A pseudodeficiency alleles is not associated with progressive neurological disease.
Penzien JM; Kappler J; Herschkowitz N; Schuknecht B; Leinekugel P; Propping P; Tønnesen T; Lou H; Moser H; Zierz S
Am J Hum Genet; 1993 Mar; 52(3):557-64. PubMed ID: 8095368
[TBL] [Abstract][Full Text] [Related]
39. Specific downregulation and mistargeting of the lipid raft-associated protein MAL in a glycolipid storage disorder.
Saravanan K; Schaeren-Wiemers N; Klein D; Sandhoff R; Schwarz A; Yaghootfam A; Gieselmann V; Franken S
Neurobiol Dis; 2004 Jul; 16(2):396-406. PubMed ID: 15193296
[TBL] [Abstract][Full Text] [Related]
40. Improved synthesis of [1-14C]acyl-sphingosine-galactose-3-sulfate (sulfatide) for diagnosis of metachromatic leukodystrophy: usefulness of radioscanning.
Masson M; Li WX; Fluharty AL; Beaucourt JP; Turpin JC; Baumann N
Clin Chim Acta; 1991 Sep; 201(3):157-68. PubMed ID: 1684534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
